EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 -0.5852
March 31, 2026 -0.5604
December 31, 2025 -0.5297
September 30, 2025 -1.381
June 30, 2025 -1.368
March 31, 2025 -1.397
December 31, 2024 -1.512
September 30, 2024 -0.5198
June 30, 2024 -0.8267
March 31, 2024 -1.091
December 31, 2023 -1.274
September 30, 2023 -1.667
June 30, 2023 -1.553
March 31, 2023 -1.446
December 31, 2022 -1.331
September 30, 2022 -1.289
June 30, 2022 -1.335
March 31, 2022 -1.360
December 31, 2021 -1.626
September 30, 2021 -1.555
June 30, 2021 -1.459
March 31, 2021 -1.398
Date Value
December 31, 2020 -1.201
September 30, 2020 -1.348
June 30, 2020 -2.436
March 31, 2020 -3.369
December 31, 2019 -3.906
September 30, 2019 -4.451
June 30, 2019 -4.170
March 31, 2019 -3.972
December 31, 2018 -4.041
September 30, 2018 -3.787
June 30, 2018 -3.36
March 31, 2018 -2.91
December 31, 2017 -2.41
September 30, 2017 -2.16
June 30, 2017 -2.03
March 31, 2017 -2.09
December 31, 2016 -2.26
September 30, 2016 -2.05
June 30, 2016 -6.66
March 31, 2016 -6.04
December 31, 2015 -5.39
September 30, 2015 -5.11

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Corcept Therapeutics, Inc. 0.4187
Alumis, Inc. -3.809
ANI Pharmaceuticals, Inc. 4.632
Veru, Inc. -0.6109
Johnson & Johnson 6.592